5 hours ago
Alpha-1 Antitrypsin Gene Editing Startup Raises $230 Million: Serapha Bio AATD Debut
A new gene-editing company called Serapha Bio emerged from stealth on June 23, 2026 with $230 million in committed financing and a one-time therapy designed to correct the genetic root cause of alpha-1 antitrypsin deficiency — a rare disease that... Read more.
More from Tech Times
Owner: Sung Kim (CEO & Founder) through Tech Times LLC
Owner: Sung Kim (CEO & Founder) through Tech Times LLC
Owner: Sung Kim (CEO & Founder) through Tech Times LLC
Search & Explore
Search the news with more context, not more noise.
Today's Media Watch
Your daily guide to the stories shaping media, journalism, and public trust.
Who Owns the Narrative?
See the impact of media framing through real-world case studies.
The EU-Mercosur
Free-trade agreements divide opinion. The EU-Mercosur deal sparked conflicting headlines, reflecting debates over prices, industry, environment, and self-sufficiency.
COVID Vaccinations
This analysis of COVID vaccination coverage shows how ideology, ownership, and political framing shape media narratives, influencing both what we think and how we think.
Greenland
This case study explores the Greenland acquisition scenario as a real-world media literacy stress test, revealing how ideology, ownership, and political framing shape the stories we consume.
Learn About Our Fact-Based Transparency System
Our proprietary bias labels help you understand each outlet’s political orientation, editorial independence, and credibility based on factors like ownership, funding, affiliations, content, and media freedom. Learn more in the Perspectify FAQ.
Learn more
